Demo with sample data. Goodward Health is a fictional group. All names and figures are invented.

Prepared by EmpowerMed

Goodward Health, Sample Client Dashboard

Multi-specialty physician group · 5 providers · Primary care, pediatrics and wound care

Period
Year to dateOctober 2026September 2026
Refreshed weekly · Updated Nov 16, 2026

Revenue Overview

Year to date, January – October 2026, by payment date · Updated Nov 16, 2026

Total payments$5,794,080Jan – Oct 2026 · Insurance $5,510,850 · Patient $283,230
Charges billed$13,978,500Jan – Oct 2026
Claims billed32,820Jan – Oct 2026
Claims paid31,874Jan – Oct 2026
Avg paid per claim$172.89Insurance paid ÷ claims paid
Collections ÷ charges41.4%Jan – Oct 2026
Avg pay lag25.7 daysPayment date − service date · Jan – Oct
$0-paid line rate10.1%Our early denial signal · Jan – Oct
Total AR$1,412,600As of Nov 16, 2026 · snapshot, not a period total
Days in AR31.6As of Nov 16, 2026
AR over 90 days14.8%As of Nov 16, 2026

Payments by month, last 12 months

Nov 2025 – Oct 2026. January through October 2026 are highlighted (year to date).

Charges vs payments by payer group

ChargesPayments

Paid by rendering provider

Includes insurance and patient payments. Total $5,794,080.

Top payers by paid, Year to date

Top payers by paid, Year to date
PayerClaims paidPaid% of periodAvg per claimPay lag$0 rate
Medicare9,321$2,003,14636.3%$214.9117.2 d5.5%
BCBS5,443$1,001,74218.2%$184.0423.6 d9.1%
Aetna4,322$780,86214.2%$180.6725.7 d10.5%
UHC4,553$718,03113.0%$157.7129 d12.8%
Cigna2,205$365,1466.6%$165.6027.9 d11.0%
Humana1,743$252,5924.6%$144.9233.3 d15.2%
Medicaid2,544$168,6203.1%$66.2836.5 d17.0%
TRICARE925$140,5452.6%$151.9440.8 d8.1%
Other818$80,1661.5%$98.0044 d19.0%
All insurance31,874$5,510,850100%$172.8925.7 d10.1%

Top 10 codes by paid (CPT / HCPCS)

Top 10 codes by paid
CodeDescriptionUnitsPaid
99214Office visit, established, moderate10,059$884,794
99213Office visit, established, low11,382$662,748
A2032Skin substitute product66$545,644
A2024Skin substitute product44$356,559
99396Preventive visit, 40-642,273$330,017
Q4322Skin substitute product30$308,038
99204Office visit, new, moderate1,815$266,829
Q4186Skin substitute product36$176,799
99215Office visit, established, high1,255$154,703
G2211Visit complexity add-on7,959$127,316

Top 5 things going well

  1. Year-to-date payments are $5,794,080 across January through October, with October the strongest month.
  2. Medicare has paid $2,003,146 year to date, about 36% of insurance collections, and remains the fastest major payer.
  3. The graft program has paid $1.41 million so far this year, a steady climb from January through October.
  4. Vaccine volume is 3,446 doses year to date, with the October flu push the largest month.
  5. Average pay lag for the year is 25.7 days, and it has been improving toward the 23.9-day October figure.

Top opportunities & action plan

  1. The year-to-date $0-paid line rate is 10.1%. It has come down each month since spring, and the November claim-scrubber update is meant to keep that trend going.
  2. Humana and Medicaid remain the slowest payers for the year. Electronic remittance for Humana and weekly Medicaid follow-up should pull those lags closer to the group average.
  3. Collections ÷ charges is 41% for the year. Your fee schedule sits well above contracted rates. A fee schedule review would make charges and AR reflect real expected value.
  4. NP Reyes was still joining several plans for much of the year. Open enrollments are on the Credentialing tab; each approval should lift new-patient volume.
  5. Patient payments are about 5% of year-to-date cash. Text-to-pay statements typically lift patient collections 10 to 15%.

October 2026, by payment date · Updated Nov 16, 2026

Total payments$683,140▲ 10.4% vs SepInsurance $651,680 · Patient $31,460
Charges billed$1,572,000▲ 5.0% vs Sep
Claims billed3,612▲ 3.6% vs Sep
Claims paid3,584▲ 5.3% vs Sep
Avg paid per claim$181.83▲ 5.1% vs SepInsurance paid ÷ claims paid
Collections ÷ charges43.5%▲ 2.1 pts vs Sep
Avg pay lag23.9 days▼ 3.6% vs SepPayment date − service date
$0-paid line rate7.4%▼ 1.2 pts vs SepOur early denial signal
Total AR$1,412,600As of Nov 16, 2026 · snapshot, not a period total
Days in AR31.6As of Nov 16, 2026
AR over 90 days14.8%As of Nov 16, 2026

Payments by month, last 12 months

Nov 2025 – Oct 2026. October is the highlighted bar.

Charges vs payments by payer group

ChargesPayments

Paid by rendering provider

Includes insurance and patient payments. Total $683,140.

Top payers by paid, October 2026

Top payers by paid, October 2026
PayerClaims paidPaid% of periodAvg per claimPay lag$0 rate
Medicare1,048$236,88036.3%$226.0316 d4.1%
BCBS612$118,46018.2%$193.5622 d6.8%
Aetna486$92,34014.2%$190.0024 d7.9%
UHC512$84,91013.0%$165.8427 d9.6%
Cigna248$43,1806.6%$174.1126 d8.2%
Humana196$29,8704.6%$152.4031 d11.4%
Medicaid286$19,9403.1%$69.7234 d12.7%
TRICARE104$16,6202.6%$159.8138 d6.1%
Other92$9,4801.5%$103.0441 d14.3%
All insurance3,584$651,680100%$181.8323.9 d7.4%

Top 10 codes by paid (CPT / HCPCS)

Top 10 codes by paid
CodeDescriptionUnitsPaid
99214Office visit, established, moderate1,186$104,320
99213Office visit, established, low1,342$78,140
A2032Skin substitute product9$71,280
A2024Skin substitute product6$46,740
Q4322Skin substitute product4$39,520
99396Preventive visit, 40-64268$38,910
99204Office visit, new, moderate214$31,460
Q4186Skin substitute product5$22,960
99215Office visit, established, high148$18,240
G2211Visit complexity add-on1,104$17,660

Top 5 things going well

  1. Total payments reached $683,140, the strongest month of the last 12 and up 10.4% over September.
  2. Medicare is paying in 16 days on average with a 4.1% $0 rate, our cleanest payer.
  3. AR over 90 days is 14.8% as of Nov 16, 2026, after our team worked the oldest UHC and Humana balances.
  4. The visit-complexity add-on (G2211) is now captured on 1,104 eligible visits, up from under 600 in July.
  5. The graft program and the flu season vaccine push together added over $200k in paid this month.

Top opportunities & action plan

  1. UHC $0 rate is 9.6%. Most are modifier 25 edits on same-day procedures. We updated the claim scrubber rule on Nov 3 and are re-billing 41 lines this week.
  2. Humana pays slowest at 31 days. We are moving Humana to electronic remittance so payments post 5 to 7 days sooner.
  3. Collections ÷ charges is 43%. Your fee schedule is set far above top payer rates. We recommend a fee schedule review so charges and AR reflect real expected value.
  4. New-patient visits (99204) dipped 6%. Two payer panels for NP Reyes are still in process; see the Credentialing tab.
  5. Patient balances are 5% of cash. Turning on text-to-pay statements typically lifts patient collections 10 to 15%.

September 2026, by payment date · Updated Nov 16, 2026

Total payments$618,940▲ 2.3% vs AugInsurance $588,310 · Patient $30,630
Charges billed$1,497,200▲ 1.0% vs Aug
Claims billed3,488▲ 1.1% vs Aug
Claims paid3,402▲ 1.6% vs Aug
Avg paid per claim$172.93▲ 0.7% vs AugInsurance paid ÷ claims paid
Collections ÷ charges41.3%▲ 0.5 pts vs Aug
Avg pay lag24.8 days▼ 3.1% vs AugPayment date − service date
$0-paid line rate8.6%▼ 0.5 pts vs AugOur early denial signal
Total AR$1,412,600As of Nov 16, 2026 · snapshot, not a period total
Days in AR31.6As of Nov 16, 2026
AR over 90 days14.8%As of Nov 16, 2026

Payments by month, last 12 months

Nov 2025 – Oct 2026. September is the highlighted bar.

Charges vs payments by payer group

ChargesPayments

Paid by rendering provider

Includes insurance and patient payments. Total $618,940.

Top payers by paid, September 2026

Top payers by paid, September 2026
PayerClaims paidPaid% of periodAvg per claimPay lag$0 rate
Medicare995$213,84636.3%$214.9216.6 d4.7%
BCBS581$106,94118.2%$184.0622.8 d7.7%
Aetna461$83,36114.2%$180.8324.9 d9.0%
UHC486$76,65313.0%$157.7228 d10.9%
Cigna235$38,9816.6%$165.8827 d9.3%
Humana186$26,9654.6%$144.9732.2 d13.0%
Medicaid272$18,0013.1%$66.1835.3 d14.5%
TRICARE99$15,0042.6%$151.5639.4 d6.9%
Other87$8,5581.5%$98.3742.5 d16.3%
All insurance3,402$588,310100%$172.9324.8 d8.6%

Top 10 codes by paid (CPT / HCPCS)

Top 10 codes by paid
CodeDescriptionUnitsPaid
99214Office visit, established, moderate1,075$94,516
99213Office visit, established, low1,216$70,797
A2032Skin substitute product8$61,280
Q4322Skin substitute product4$39,490
A2024Skin substitute product5$38,950
99396Preventive visit, 40-64243$35,253
99204Office visit, new, moderate194$28,503
Q4186Skin substitute product4$20,780
99215Office visit, established, high134$16,526
G2211Visit complexity add-on1,000$16,000

Top 5 things going well

  1. Total payments were $618,940 in September, up 2.3% over August and the second-strongest month of the last 12.
  2. Medicare paid in 16.6 days on average, still the cleanest major payer.
  3. Collections ÷ charges improved to 41.3% from 40.8% in August.
  4. The graft program paid $163,700, already close to the later October high.
  5. Average pay lag improved to 24.8 days from 25.6 days in August.

Top opportunities & action plan

  1. The $0-paid line rate was 8.6%. Eligibility and modifier 25 edits were the main drivers. The scrubber update in early November is aimed at this.
  2. Humana and Medicaid were the slowest payers. Electronic remittance for Humana and a weekly follow-up list for Medicaid were already in motion by month-end.
  3. Collections ÷ charges is still 41%. A fee schedule review would bring charges closer to contracted rates so AR reflects real expected value.
  4. NP Reyes was still out of network with several plans in September. See the Credentialing tab for the enrollments that opened in October and November.
  5. Patient collections were about 5% of cash. Text-to-pay statements would typically lift patient collections 10 to 15%.

AR & Denials

AR snapshot as of Nov 16, 2026. Aging, payer balances and open claims do not change with the period menu. Denial counts and the $0-paid rate follow the menu.

Total AR$1,412,600As of Nov 16, 2026
Days in AR31.6Goal: under 35 · As of Nov 16, 2026
AR over 90 days14.8%$209,000 · As of Nov 16, 2026
$0-paid line rate10.1%Jan – Oct 2026 · Our early denial signal
Denied lines5,062Of 71,890 claim lines · Jan – Oct
Appeals won (YTD)75%412 of 549 appeals
$0-paid line rate7.4%▼ 1.2 pts vs Sep
Denied lines412▼ 8.4% vs SepOf 7,912 claim lines
Appeals won (30 days)78%▲ 6.0 pts vs Sep53 of 68 appeals
$0-paid line rate8.6%▼ 0.5 pts vs Aug
Denied lines450▼ 4.5% vs AugOf 7,640 claim lines
Appeals won (30 days)72%▲ 2.0 pts vs Aug48 of 67 appeals

AR aging

AR aging buckets
BucketBalanceClaims% of AR
0–30 days$825,0001,84658.4%
31–60 days$243,00061217.2%
61–90 days$135,6003189.6%
91–120 days$89,0001876.3%
120+ days$120,0002418.5%
Total$1,412,6003,204100%

Snapshot as of Nov 16, 2026. These balances do not change with the period menu.

AR by payer

AR by payer
PayerBalance% over 90
Medicare$412,8006.6%
BCBS$268,40012.9%
UHC$221,70021.4%
Aetna$186,30014.1%
Cigna$88,90013.6%
Humana$76,20024.8%
Medicaid$58,40027.3%
TRICARE$41,70018.2%
Other / self-pay$58,20031.5%
Total$1,412,60014.8%

Snapshot as of Nov 16, 2026.

Denials by reason, Year to date

5,062 denied lines, January through October 2026. Other $0 lines went to patient deductible or were paid in a bundled line.

Denials by reason, October 2026

412 denied lines in October 2026. Other $0 lines went to patient deductible or were paid in a bundled line.

Denials by reason, September 2026

450 denied lines in September 2026. Other $0 lines went to patient deductible or were paid in a bundled line.

AR & denial trend, last 6 months

AR and denial trend, May to October 2026
MonthDays in ARAR over 90$0 rateDenied lines
May38.221.4%10.9%521
Jun36.920.1%10.2%498
Jul36.119.3%9.7%486
Aug35.418.2%9.1%471
Sep33.916.9%8.6%450
Oct31.614.8%7.4%412

Days in AR and AR over 90 days are snapshots (latest as of Nov 16). $0 rate and denied lines are monthly. Every measure has improved five months in a row.

Outstanding claims, payer issues

Outstanding claims with payer issues
PayerIssueClaimsUnpaidAvgStatus
UHCModifier 25 edit on same-day procedure41$7,380$180Corrected, re-billed
HumanaPayer ID change, claims rejected at clearinghouse27$4,860$180Delayed by payer ID
AetnaGraft records requested3$24,600$8,200Records sent 11/6
BCBSPrior auth on file not linked to claim12$3,240$270Reprocessing requested
MedicaidSubmitted, no response after 45 days18$2,160$120Submitted / unpaid
CignaUnderpaid vs contract rate22$1,980$90Appeal filed 11/9

Open items as of Nov 16, 2026. This list does not change with the period menu.

How to read this tab

Days in AR: total AR ÷ average daily charges, as of the snapshot date. Under 35 days is healthy for a group like yours. It does not change with the period menu.

AR over 90 days: the share of your balance older than 90 days as of the snapshot date. This is the money most at risk.

$0-paid line rate: claim lines a payer paid at $0 in the selected period. It is our early warning for denials, before the remit codes come back.

Top 5 things going well

  1. Days in AR is 31.6 as of Nov 16, 2026, back under our 35-day goal.
  2. 0–30 day AR is 58% of the total, which means new claims are paying on schedule.
  3. Eligibility denials have been trending down since real-time eligibility checks started at check-in.
  4. 78% of appeals filed in the last 30 days were overturned.
  5. Medicare AR over 90 days is only 6%.

Top opportunities & action plan

  1. Eligibility is still the top denial reason. We will send the front desk a weekly list of patients with coverage changes before their visit.
  2. Humana claims are held up by a payer ID change. We updated the payer ID on Nov 12 and are resubmitting all 27 claims this week.
  3. Medicaid has 27% of its balance over 90 days. We escalated 18 unanswered claims to provider relations and will call weekly until they pay.
  4. Prior auth denials remain a steady share of denied lines. We are adding an auth-required check at scheduling for imaging, injections and grafts.
  5. Three Aetna graft claims total $24.6k. Wound photos and measurements went in Nov 6. We follow up every 7 days.

Wound Care & Grafts

Year to date, January – October 2026, graft program, by payment date · Updated Nov 16, 2026

Grafts applied176Application events · Jan – Oct 2026
Graft product paid$1,387,040Jan – Oct 2026
Application paid$26,191Jan – Oct 2026
Total graft program$1,413,231Product is 98.1% of graft dollars · Jan – Oct
Avg paid per graft$8,406Paid product lines only · Jan – Oct

Product & application breakdown by code

Graft product and application breakdown by code
CodeDescriptionCategoryLinesPaidAvg paidPaid lines$0 linesDenial %
A2032Skin substitute, per sq cmProduct66$545,644$8,8016246%
A2024Skin substitute, per sq cmProduct44$356,559$8,4904225%
Q4186Skin substitute, per sq cmProduct36$176,799$5,3583338%
Q4322Skin substitute, per sq cmProduct30$308,038$11,0012827%
15271Application, trunk/arms/legs, first 25 sq cmApplication109$11,690$126931615%
15272Application, each additional 25 sq cmApplication70$2,918$62472333%
15273Application, trunk/arms/legs, first 100 sq cmApplication62$9,305$17254813%
15274Application, each additional 100 sq cmApplication40$2,278$95241640%
Total457$1,413,2313837416%

Grafts by provider

Grafts by provider
ProviderGraftsProduct paidApplication paidTotal
Dr. Elena Marsh110$871,516$16,820$888,336
Dr. Victor Hale44$344,634$6,144$350,778
NP Jordan Reyes22$170,890$3,227$174,117
Total176$1,387,040$26,191$1,413,231

Graft payments by month

Graft product paid, payer × product

Graft product paid by payer and product
PayerA2032A2024Q4186Q4322Total
Medicare$368,662$172,440$105,039$231,011$877,152
BCBS$109,500$63,893—$77,027$250,420
Aetna$67,482$60,285$71,760—$199,527
UHC—$59,941——$59,941
Total$545,644$356,559$176,799$308,038$1,387,040

Graft program, last 6 months

Graft program summary, May to October 2026
MonthGraftsProduct paidApplication paidTotal paidAvg paid per graftProduct $0 rate
May17$135,720$2,480$138,200$8,4826%
Jun18$143,690$2,610$146,300$8,4526%
Jul19$150,140$2,760$152,900$8,3415%
Aug19$147,110$2,690$149,800$8,1735%
Sep21$160,500$3,200$163,700$8,0255%
Oct24$180,500$3,331$183,831$8,2058%
6 months118$917,660$17,071$934,731$8,2676%

Grafts are up 41% since May while avg paid per graft held between $8,000 and $8,500. Year-to-date figures above include January through April as well.

How to read this tab

Product vs application: product is the skin substitute itself, billed per sq cm. Application is the procedure code for placing it.

Avg paid per graft: product paid ÷ product lines paid above $0, so one denied line does not drag the average down.

Denial %: lines paid at $0 ÷ all lines for that code in the selected period. Add-on codes deny most often, so we watch them closely.

Top 5 things going well

  1. The graft program has paid $1,413,231 year to date, with volume rising from 14 grafts in January to 24 in October.
  2. Average paid per graft is $8,406 on 165 paid product lines.
  3. Product dollars are 98% of the program; application codes are a small, steady share.
  4. Dr. Marsh has applied 110 of the 176 grafts this year.
  5. Medicare remains the largest graft payer across every product.

Top opportunities & action plan

  1. Add-on application codes have the highest $0 rates for the year. Unit-to-wound-size checks before billing are meant to bring those denials down.
  2. A few product lines still deny for diagnosis or prior auth. Covered-diagnosis and UHC auth checks are now in the visit workflow.
  3. Aetna records requests have held up a handful of large claims. We now send photos and measurements with the first submission when we can.
  4. Humana has no graft product payments in the payer grid. That is a coverage mix, not a $0: Humana volume in this program is very small.
  5. Product cost is not tracked yet. Share invoice cost per product and we will add margin per graft to this tab.

October 2026, graft program, by payment date · Updated Nov 16, 2026

Grafts applied24▲ 14.3% vs SepApplication events
Graft product paid$180,500▲ 12.5% vs Sep
Application paid$3,331▲ 4.1% vs Sep
Total graft program$183,831▲ 12.3% vs SepProduct is 98.2% of graft dollars
Avg paid per graft$8,205▲ 2.2% vs SepPaid product lines only

Product & application breakdown by code

Graft product and application breakdown by code
CodeDescriptionCategoryLinesPaidAvg paidPaid lines$0 linesDenial %
A2032Skin substitute, per sq cmProduct9$71,280$8,9108111%
A2024Skin substitute, per sq cmProduct6$46,740$7,790600%
Q4186Skin substitute, per sq cmProduct5$22,960$5,7404120%
Q4322Skin substitute, per sq cmProduct4$39,520$9,880400%
15271Application, trunk/arms/legs, first 25 sq cmApplication14$1,488$12412214%
15272Application, each additional 25 sq cmApplication9$372$626333%
15273Application, trunk/arms/legs, first 100 sq cmApplication8$1,183$1697112%
15274Application, each additional 100 sq cmApplication5$288$963240%
Total60$183,831501017%

Grafts by provider

Grafts by provider
ProviderGraftsProduct paidApplication paidTotal
Dr. Elena Marsh15$113,420$2,140$115,560
Dr. Victor Hale6$44,860$780$45,640
NP Jordan Reyes3$22,220$411$22,631
Total24$180,500$3,331$183,831

Graft payments by month

Graft product paid, payer × product

Graft product paid by payer and product
PayerA2032A2024Q4186Q4322Total
Medicare$48,190$22,610$13,780$29,640$114,220
BCBS$14,260$8,240—$9,880$32,380
Aetna$8,830$7,790$9,180—$25,800
UHC—$8,100——$8,100
Total$71,280$46,740$22,960$39,520$180,500

Graft program, last 6 months

Graft program summary, May to October 2026
MonthGraftsProduct paidApplication paidTotal paidAvg paid per graftProduct $0 rate
May17$135,720$2,480$138,200$8,4826%
Jun18$143,690$2,610$146,300$8,4526%
Jul19$150,140$2,760$152,900$8,3415%
Aug19$147,110$2,690$149,800$8,1735%
Sep21$160,500$3,200$163,700$8,0255%
Oct24$180,500$3,331$183,831$8,2058%
6 months118$917,660$17,071$934,731$8,2676%

Grafts are up 41% since May while avg paid per graft held between $8,000 and $8,500. Year-to-date figures above include January through April as well.

How to read this tab

Product vs application: product is the skin substitute itself, billed per sq cm. Application is the procedure code for placing it.

Avg paid per graft: product paid ÷ product lines paid above $0, so one denied line does not drag the average down.

Denial %: lines paid at $0 ÷ all lines for that code in the selected period. Add-on codes deny most often, so we watch them closely.

Top 5 things going well

  1. Graft program paid $183,831 in October, the best month this year.
  2. Average paid per graft is $8,205, holding steady as volume grew.
  3. Medicare graft claims paid with no product denials this month.
  4. Every graft claim now goes out with wound size, location and product lot number attached.
  5. Q4322 paid 4 of 4 lines at an average near $9,900.

Top opportunities & action plan

  1. Add-on application codes deny most often. 15272 and 15274 denied 5 of 14 lines. We are checking units against the documented wound size before billing.
  2. Q4186 had one $0 line. The plan wanted a different covered diagnosis. We corrected the code and appealed on Nov 10.
  3. Three Aetna claims are waiting on records. Records went Nov 6. Expect payment within 30 days of review.
  4. UHC requires prior auth for A2024. We now request auth at the wound care visit before the product is ordered.
  5. Product cost is not tracked yet. Share invoice cost per product and we will add margin per graft to this tab.

September 2026, graft program, by payment date · Updated Nov 16, 2026

Grafts applied21▲ 10.5% vs AugApplication events
Graft product paid$160,500▲ 9.1% vs Aug
Application paid$3,200▲ 19.0% vs Aug
Total graft program$163,700▲ 9.3% vs AugProduct is 98.0% of graft dollars
Avg paid per graft$8,025▼ 1.8% vs AugPaid product lines only

Product & application breakdown by code

Graft product and application breakdown by code
CodeDescriptionCategoryLinesPaidAvg paidPaid lines$0 linesDenial %
A2032Skin substitute, per sq cmProduct8$61,280$8,7547112%
A2024Skin substitute, per sq cmProduct5$38,950$7,790500%
Q4186Skin substitute, per sq cmProduct4$20,780$5,195400%
Q4322Skin substitute, per sq cmProduct4$39,490$9,872400%
15271Application, trunk/arms/legs, first 25 sq cmApplication13$1,420$12911215%
15272Application, each additional 25 sq cmApplication8$350$705338%
15273Application, trunk/arms/legs, first 100 sq cmApplication7$1,140$1906114%
15274Application, each additional 100 sq cmApplication5$290$973240%
Total54$163,70045917%

Grafts by provider

Grafts by provider
ProviderGraftsProduct paidApplication paidTotal
Dr. Elena Marsh13$100,800$2,050$102,850
Dr. Victor Hale5$39,800$760$40,560
NP Jordan Reyes3$19,900$390$20,290
Total21$160,500$3,200$163,700

Graft payments by month

Graft product paid, payer × product

Graft product paid by payer and product
PayerA2032A2024Q4186Q4322Total
Medicare$41,200$18,800$11,400$29,600$101,000
BCBS$12,600$7,900—$9,890$30,390
Aetna$7,480$7,350$9,380—$24,210
UHC—$4,900——$4,900
Total$61,280$38,950$20,780$39,490$160,500

Graft program, last 6 months

Graft program summary, May to October 2026
MonthGraftsProduct paidApplication paidTotal paidAvg paid per graftProduct $0 rate
May17$135,720$2,480$138,200$8,4826%
Jun18$143,690$2,610$146,300$8,4526%
Jul19$150,140$2,760$152,900$8,3415%
Aug19$147,110$2,690$149,800$8,1735%
Sep21$160,500$3,200$163,700$8,0255%
Oct24$180,500$3,331$183,831$8,2058%
6 months118$917,660$17,071$934,731$8,2676%

Grafts are up 41% since May while avg paid per graft held between $8,000 and $8,500. Year-to-date figures above include January through April as well.

How to read this tab

Product vs application: product is the skin substitute itself, billed per sq cm. Application is the procedure code for placing it.

Avg paid per graft: product paid ÷ product lines paid above $0, so one denied line does not drag the average down.

Denial %: lines paid at $0 ÷ all lines for that code in the selected period. Add-on codes deny most often, so we watch them closely.

Top 5 things going well

  1. Graft program paid $163,700 in September, up from August and already close to the later October high.
  2. Average paid per graft is $8,025, in the same $8,000 to $8,500 range as the rest of the year.
  3. 21 grafts were applied, 3 more than August.
  4. Q4322 paid all 4 lines.
  5. Dr. Marsh continues to drive most of the graft volume.

Top opportunities & action plan

  1. Add-on application codes denied most often. We started checking units against documented wound size before billing, ahead of the October claims.
  2. A2032 had one $0 line. The diagnosis on the claim did not match the plan's covered list. It was corrected the following week.
  3. Aetna records requests were already open by month-end. Photos and measurements went in Nov 6.
  4. UHC prior auth for A2024 was still being built into the visit workflow. Auth is now requested at the wound care visit before the product is ordered.
  5. Product cost is not tracked yet. Share invoice cost per product and we will add margin per graft to this tab.

Vaccines

Year to date, January – October 2026, vaccine program, by payment date · Updated Nov 16, 2026

Doses given3,446VFC 1,522 · Private 1,924 · Jan – Oct
Billed$437,846Product + admin charges · Jan – Oct
Paid$323,565Product $218,110 · Admin $105,455
Paid per dose$93.90Jan – Oct 2026
$0-paid rate4.2%Excludes VFC product lines · Jan – Oct

Vaccine product by code

Vaccine product breakdown by CPT code
CPTVaccineDosesVFCPrivatePaidPaid per private dose
90686Influenza, quadrivalent506204302$6,252$20.70
90670Pneumococcal conjugate (PCV)554247307$69,320$225.80
90651HPV, 9-valent460177283$75,934$268.32
90716Varicella434203231$32,838$142.16
90707MMR462216246$20,281$82.44
90700DTaP538246292$8,114$27.79
90648Hib492229263$5,371$20.42
Total3,4461,5221,924$218,110$113.36

VFC (Vaccines for Children) doses are state-supplied, so only the administration is paid.

Administration codes

Vaccine administration codes
CPTDescriptionUnitsPaidPaid per unit
90460Admin with counseling, first component1,761$40,679$23.10
90461Admin with counseling, each additional component1,404$20,779$14.80
90471Admin, first injection1,275$31,365$24.60
90472Admin, each additional injection831$12,632$15.20
Total5,271$105,455

VFC vs private stock

VFC vs private stock
StockDosesPaidPaid per dose
VFC1,522$32,875$21.60
Private stock1,924$290,690$151.09

VFC is paid for administration only. Private stock is paid for product plus administration.

Doses by month

Paid by vaccine, private stock

Vaccine program, last 6 months

Vaccine program summary, May to October 2026
MonthDosesVFCPrivatePaidPaid per dose$0 rate
May248112136$24,180$97.504.6%
Jun302131171$29,410$97.384.4%
Jul389176213$36,920$94.914.3%
Aug446198248$41,240$92.474.1%
Sep401172229$36,701$91.524.0%
Oct526225301$45,514$86.533.2%
6 months2,3121,0141,298$213,965$92.55

Late-summer checkups (Jul–Aug) and flu season (Oct) drive the peaks. HPV and PCV are most of the product dollars. Year-to-date figures above also include January through April.

How to read this tab

VFC: Vaccines for Children stock is state-supplied for eligible patients, so only the administration is billed.

Paid per dose: all vaccine paid, product plus administration, ÷ doses given, VFC doses included, for the selected period.

Admin codes: 90460/90461 apply to counseling visits under age 19. 90471/90472 apply otherwise.

Top 5 things going well

  1. 3,446 doses have been given year to date, including the October flu peak.
  2. Vaccine collections are $323,565, with HPV and PCV the largest product lines.
  3. VFC accounts for 44% of doses; those visits are paid for administration only.
  4. Counseling codes 90460/90461 are billed on eligible visits under age 19.
  5. Paid per dose is a little lower in the fall because flu doses are a larger share of the mix.

Top opportunities & action plan

  1. Some 90461 units have been missed on combination vaccines. We are auditing those visits and re-billing short units.
  2. HPV series completion is low for the year. A recall text list would close the gap on dose 2.
  3. A few plans have paid PCV below contract. We are checking BCBS and Aetna vaccine payments against the contracted rate and will appeal shortfalls.
  4. VFC stock was used for a handful of privately insured patients. An eligibility check is now on the VFC log.
  5. No dose-level inventory view yet. Share the monthly lot log and we will add on-hand vs used to this tab.

October 2026, vaccine program, by payment date · Updated Nov 16, 2026

Doses given526▲ 31.2% vs SepVFC 225 · Private 301
Billed$61,840▲ 24.0% vs SepProduct + admin charges
Paid$45,514▲ 24.0% vs SepProduct $29,388 · Admin $16,126
Paid per dose$86.53▼ 5.5% vs SepMore low-cost flu doses
$0-paid rate3.2%▼ 0.8 pts vs SepExcludes VFC product lines

Vaccine product by code

Vaccine product breakdown by CPT code
CPTVaccineDosesVFCPrivatePaidPaid per private dose
90686Influenza, quadrivalent18674112$2,397$21.40
90670Pneumococcal conjugate (PCV)723339$9,411$241.31
90651HPV, 9-valent521834$9,772$287.41
90716Varicella462125$3,815$152.60
90707MMR482226$2,301$88.50
90700DTaP643034$1,013$29.79
90648Hib582731$679$21.90
Total526225301$29,388$97.63

VFC (Vaccines for Children) doses are state-supplied, so only the administration is paid.

Administration codes

Vaccine administration codes
CPTDescriptionUnitsPaidPaid per unit
90460Admin with counseling, first component268$6,191$23.10
90461Admin with counseling, each additional component214$3,167$14.80
90471Admin, first injection196$4,822$24.60
90472Admin, each additional injection128$1,946$15.20
Total806$16,126

VFC vs private stock

VFC vs private stock
StockDosesPaidPaid per dose
VFC225$4,860$21.60
Private stock301$40,654$135.06

VFC is paid for administration only. Private stock is paid for product plus administration.

Doses by month

Paid by vaccine, private stock

Vaccine program, last 6 months

Vaccine program summary, May to October 2026
MonthDosesVFCPrivatePaidPaid per dose$0 rate
May248112136$24,180$97.504.6%
Jun302131171$29,410$97.384.4%
Jul389176213$36,920$94.914.3%
Aug446198248$41,240$92.474.1%
Sep401172229$36,701$91.524.0%
Oct526225301$45,514$86.533.2%
6 months2,3121,0141,298$213,965$92.55

Late-summer checkups (Jul–Aug) and flu season (Oct) drive the peaks. HPV and PCV are most of the product dollars. Year-to-date figures above also include January through April.

How to read this tab

VFC: Vaccines for Children stock is state-supplied for eligible patients, so only the administration is billed.

Paid per dose: all vaccine paid, product plus administration, ÷ doses given, VFC doses included, for the selected period.

Admin codes: 90460/90461 apply to counseling visits under age 19. 90471/90472 apply otherwise.

Top 5 things going well

  1. 526 doses given in October, up 31% as flu season started.
  2. Administration codes paid on 97% of lines, including VFC doses.
  3. HPV and PCV paid more than $240 per private dose on average.
  4. Counseling codes 90460/90461 are billed on every eligible visit under age 19.
  5. Saturday flu clinics added 118 doses this month.

Top opportunities & action plan

  1. Some 90461 units are missing. Combination vaccines need one 90461 per extra component. We found 22 short units and re-billed them.
  2. HPV series completion is low. Only 41% of patients came back for dose 2. A recall text list would close this gap.
  3. Two plans paid PCV below contract. We are checking every BCBS and Aetna vaccine payment against the contracted rate and will appeal any shortfall.
  4. VFC stock was used for 3 privately insured patients. We flagged them for stock replacement and added an eligibility check to the VFC log.
  5. No dose-level inventory view yet. Share the monthly lot log and we will add on-hand vs used to this tab.

September 2026, vaccine program, by payment date · Updated Nov 16, 2026

Doses given401▼ 10.1% vs AugVFC 172 · Private 229
Billed$49,866▼ 10.5% vs AugProduct + admin charges
Paid$36,701▼ 11.0% vs AugProduct $24,596 · Admin $12,105
Paid per dose$91.52▼ 1.0% vs Aug
$0-paid rate4.0%▼ 0.1 pts vs AugExcludes VFC product lines

Vaccine product by code

Vaccine product breakdown by CPT code
CPTVaccineDosesVFCPrivatePaidPaid per private dose
90686Influenza, quadrivalent1224874$1,584$21.41
90670Pneumococcal conjugate (PCV)663036$8,687$241.31
90651HPV, 9-valent441628$8,047$287.39
90716Varicella381820$3,052$152.60
90707MMR422022$1,947$88.50
90700DTaP482226$775$29.81
90648Hib411823$504$21.91
Total401172229$24,596$107.41

VFC (Vaccines for Children) doses are state-supplied, so only the administration is paid.

Administration codes

Vaccine administration codes
CPTDescriptionUnitsPaidPaid per unit
90460Admin with counseling, first component210$4,851$23.10
90461Admin with counseling, each additional component165$2,442$14.80
90471Admin, first injection140$3,444$24.60
90472Admin, each additional injection90$1,368$15.20
Total605$12,105

VFC vs private stock

VFC vs private stock
StockDosesPaidPaid per dose
VFC172$3,715$21.60
Private stock229$32,986$144.04

VFC is paid for administration only. Private stock is paid for product plus administration.

Doses by month

Paid by vaccine, private stock

Vaccine program, last 6 months

Vaccine program summary, May to October 2026
MonthDosesVFCPrivatePaidPaid per dose$0 rate
May248112136$24,180$97.504.6%
Jun302131171$29,410$97.384.4%
Jul389176213$36,920$94.914.3%
Aug446198248$41,240$92.474.1%
Sep401172229$36,701$91.524.0%
Oct526225301$45,514$86.533.2%
6 months2,3121,0141,298$213,965$92.55

Late-summer checkups (Jul–Aug) and flu season (Oct) drive the peaks. HPV and PCV are most of the product dollars. Year-to-date figures above also include January through April.

How to read this tab

VFC: Vaccines for Children stock is state-supplied for eligible patients, so only the administration is billed.

Paid per dose: all vaccine paid, product plus administration, ÷ doses given, VFC doses included, for the selected period.

Admin codes: 90460/90461 apply to counseling visits under age 19. 90471/90472 apply otherwise.

Top 5 things going well

  1. 401 doses were given in September, ahead of the October flu peak.
  2. HPV and PCV again made up most of the product dollars, at more than $240 per private dose.
  3. Administration codes paid on the great majority of lines, including VFC doses.
  4. Counseling codes 90460/90461 were billed on eligible visits under age 19.
  5. Paid per dose was $91.52, a little higher than October because the mix had fewer low-cost flu doses.

Top opportunities & action plan

  1. Some 90461 units were still being missed. We audited combination-vaccine visits and re-billed short units in November.
  2. HPV series completion was already a concern. A recall text list would bring more patients back for dose 2.
  3. A few PCV payments came in below contract. BCBS and Aetna vaccine payments are being checked against the contracted rate.
  4. VFC vs private stock still needed a tighter eligibility check. That check is now on the VFC log.
  5. No dose-level inventory view yet. Share the monthly lot log and we will add on-hand vs used to this tab.

Credentialing

Credentialing Report, week of Nov 16, 2026 · Source updated Nov 14, 2026 · Not tied to the billing-period menu

Credentialing report

Credentialing Report, week of Nov 16, 2026

Goodward Health · 5 providers · 8 plans · Source updated Nov 14, 2026

29 of 38 provider enrollments are approved. NP Reyes is the only provider still moving through plans, and two of those enrollments need something from you this week.

29Approved / in network
of 38 enrollments
6In process
(incl. on hold, not started)
2Needs action
from you
1Denied or
closed
76%Complete
(NA excluded)

29 of 38 enrollments approved. NA (plans a provider does not need) is excluded.

Action needed from you

  • NP Reyes, BCBS: sign and return the updated participation agreement we emailed Nov 13.
  • NP Reyes, Cigna: the plan needs a copy of the current DEA registration. Please upload it to the shared folder by Nov 20.
  • Dr. Hale: re-attest the online credentialing profile by Dec 4 (we can walk you through it in 5 minutes).

What changed this week

  • Aetna approved NP Reyes, effective 11/1/26.
  • Humana put NP Reyes on hold until the BCBS agreement is signed.
  • UHC confirmed Dr. Natarajan’s application is complete and in review.
  • We opened a follow-up case with TRICARE on Dr. Natarajan (day 104).

Provider × plan status

Provider by plan credentialing status
ProviderMedicareMedicaidAetnaBCBSUHCCignaHumanaTRICARE
Dr. Elena MarshWound careApproved3/1/24Approved5/1/24Approved4/15/24Approved6/1/24Approved5/15/24Approved7/1/24Approved8/1/24Approved9/1/24
Dr. Victor HaleInternal medicineApproved1/1/23Approved2/1/23Approved3/1/23Approved2/15/23Approved4/1/23Approved3/15/23Approved5/1/23Not acceptingPanel closed
Dr. Priya NatarajanPediatricsApproved7/1/25Approved8/1/25Approved9/1/25Approved8/15/25In processSub 9/22/26Approved10/1/25NAIn processSub 8/4/26
NP Jordan ReyesFamily medicineApproved10/1/26In processSub 9/8/26Approved11/1/26Waiting on youSub 9/15/26In processSub 9/15/26Needs attentionSub 9/29/26On holdSub 10/2/26Not started
Dr. Samuel OrtegaFamily medicineApproved6/1/22Approved6/1/22Approved7/1/22Approved7/1/22Approved8/1/22Approved8/1/22Approved9/1/22NA

What the colors mean

ApprovedIn processWaiting on youNeeds attentionOn holdNot startedNot acceptingNA

Dates show the effective date when approved, or the submitted date while in process.

Expiring or due for renewal

Expiring or due for renewal
ItemProviderDueDays leftWho’s on it
Online credentialing profile re-attestDr. Victor HaleDec 4, 202618You (we prep it)
Malpractice policyDr. Samuel OrtegaJan 15, 202760You, send renewal
State medical licenseDr. Priya NatarajanFeb 28, 2027104EmpowerMed reminder
DEA registrationNP Jordan ReyesMar 31, 2027135EmpowerMed reminder
Medicare revalidationDr. Victor HaleJun 30, 2027226EmpowerMed

Avg days in process, by plan type

Open applications only, as of Nov 14.

Typical timelines

  • Medicare30–60 days
  • Commercial plans60–120 days
  • TRICARE / VA90–180 days
  • Re-credentialingAbout every 3 years

Effective date is the first date of service a plan will pay for. We track it so no visit is billed early.

Top 5 things going well

  1. 76% of enrollments are approved, up from 71% a month ago.
  2. Aetna approved NP Reyes in 47 days, well inside the normal range.
  3. Dr. Marsh is in network with all 8 plans, which protects the graft program.
  4. Every open application has a follow-up date, and none has gone 14 days without contact.
  5. No license or malpractice policy lapses in the next 60 days.

Top opportunities & action plan

  1. NP Reyes has 6 plans still open. Two need your signature or documents this week. Once returned, we expect BCBS and Cigna by mid-December.
  2. TRICARE for Dr. Natarajan is at day 104. Within the 90–180 day norm. We opened a case and will call every 10 days.
  3. Cigna flagged NP Reyes’ application. The DEA copy on file expired. Upload the current one and we resubmit the same day.
  4. Humana is on hold. It releases automatically once the BCBS agreement is signed. No extra action needed.
  5. Dr. Hale is closed at TRICARE. The panel is full in your area. We will reapply when it reopens and check monthly.

Want a dashboard like this for your practice?

EmpowerMed handles billing, coding and credentialing for physician groups, and every client gets a clear monthly dashboard built from their own data.

Sample dashboard for illustration only. Goodward Health, its providers and all figures are fictional and do not represent any EmpowerMed client.